Robert Naylor
Chief Executive Officer at INTUITIVE INVESTMENTS GROUP PLC
Net worth: 718 523 $ as of 2024-04-29
Network origin in Robert Naylor first degree
| Entity | Entity type | Industry | |
|---|---|---|---|
| Mutual Fd-Closed End | Investment Trusts/Mutual Funds | 12 | |
| Public Company | Financial Conglomerates | 8 | |
| Public Company | Information Technology Services | 3 |
Chart of Companies connected to the second degree
Multi-company connection
Companies connected to Robert Naylor via their personal network
| Company | Sector | Related people | Main position |
|---|---|---|---|
BBI Diagnostics Group Ltd.
 BBI Diagnostics Group Ltd. Medical SpecialtiesHealth Technology BBI Diagnostics Group Ltd. develops and manufactures raw materials and finished test platforms for the in-vitro diagnostics market. The firm’s products include cell culture reagents, conjugates, depleted serum, disease state plasma, enzymes, finished kits, gold nanoparticles, monoclonal antibodies, normal serums, patient samples, polyclonal antibodies, recombinant antibodies, silver nanoparticles, biothreat and explosives antibodies. It’s services include custom conjugation, lateral flow assay development, 3DNA pushing assay sensitivity to the limit, test optimisation, atomo rapid platform and the novarum reader. The company was founded by John Chandler in 1986 and is headquartered in Cardiff, the United Kingdom. | Medical Specialties | Chairman Chief Executive Officer | |
HICL Infrastructure Co. Ltd.
 HICL Infrastructure Co. Ltd. Investment ManagersFinance HICL Infrastructure Co. Ltd. is a closed-end investment company, which engages in the investment in infrastructure which is currently predominately in private finance initiatives and public private partnership companies. Its portfolio sectors include accommodation; education; fire, law, and order; health; transport; and water. The company was founded on March 29, 2006 and is headquartered in London, the United Kingdom. | Investment Managers | Director/Board Member | |
J.O. Hambro Capital Management Ltd.
 J.O. Hambro Capital Management Ltd. Investment ManagersFinance J.O. Hambro Capital Management Ltd. (JOHCM) is an investment management firm headquartered in London, UK. The firm was founded by James Hambro in 1993 as an independently managed boutique, and was acquired by Pendal Group Ltd., formerly BT Investment Management Ltd., in 2011. In 2023, Perpetual Limited (ASX: PPT) – an ASX-listed, global diversified financial services company in Sydney, Australia – acquired Pendal Group, including JOHCM. The firm provides discretionary investment advisory services across a diverse range of equity strategies through pooled vehicles (or investment funds) and to clients that establish separately managed accounts. | Investment Managers | Founder | |
| AXIS-SHIELD LTD | Medical Specialties | Corporate Secretary President | |
| University of Cambridge | College/University | Graduate Degree | |
| The University of Edinburgh | College/University | Undergraduate Degree Undergraduate Degree | |
Quotient Diagnostics Ltd.
 Quotient Diagnostics Ltd. Medical SpecialtiesHealth Technology Quotient Diagnostics Ltd. develops diabetes testing technology. It offers pharmaceuticals, in vitro diagnostics and medical devices. The company was founded in December 2002 and is headquartered in Walton-on-Thames, the United Kingdom. | Medical Specialties | Chairman Director/Board Member | |
The Institute of Chartered Accountants of Scotland
 The Institute of Chartered Accountants of Scotland Miscellaneous Commercial ServicesCommercial Services The Institute of Chartered Accountants of Scotland operates as a professional membership organization. The non-profit company is based in Edinburgh, UK. The British company was founded by Janice Margaret Brown and Sundeep Bahanda. The CEO is Bruce Cartwright. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
The UK Innovation & Science Seed Fund LP
 The UK Innovation & Science Seed Fund LP Investment ManagersFinance The UK Innovation & Science Seed Fund LP, an evergreen fund, invests in seed-stage companies located in the United Kingdom. It targets companies operating in biotechnology, synthetic biology, engineering, agriculture, computer science, and environmental technology sectors. It provides equity financing for seed to early-stage transactions. | Investment Managers | Director/Board Member | |
Cytox Ltd.
 Cytox Ltd. Medical DistributorsDistribution Services Cytox Ltd. develops products and services for neurodegenerative disorders. It develops cellular and genetic assays for Alzheimer’s disease diagnosis. The firm offers biomarker services to pharmaceutical companies conducting clinical trials with drugs for the treatment of AD and mild cognitive impairment; and drug-screening services. The company was founded by Zsuzsanna Nagy, Margaret Esiri, Roy Bicknell and James S. Chadwick in 2004 and is headquartered in Oxford, the United Kingdom. | Medical Distributors | Chairman | |
360 Genomics Ltd.
 360 Genomics Ltd. Pharmaceuticals: MajorHealth Technology 360 Genomics Ltd. provides pharmaceutical services. It develops PCR based detection system, a product that works in tandem with PointMan designed to detect non-wild type gene sequences by means of fluorescent tags. The company was founded on July 23, 2007 and is headquartered in South Glamorgan, the United Kingdom. | Pharmaceuticals: Major | Director/Board Member | |
DxS Ltd.
 DxS Ltd. Medical SpecialtiesHealth Technology DxS Ltd. is a personalized medicine company which engages in the development and manufacture of companion diagnostic products. Its products make use of molecular diagnostics to aid doctors and drug companies in selecting therapies for patients. It offers its products, technology, and services to the healthcare industry to enable the delivery of safe and effective medicines. The company was founded by David Whitcombe in 2001 is headquartered in Manchester, the United Kingdom. | Medical Specialties | Chairman | |
| States of Guernsey | Corporate Officer/Principal | ||
| EKF DIAGNOSTICS HOLDINGS PLC | Medical Specialties | Director/Board Member Chairman Chairman Chief Tech/Sci/R&D Officer | |
Onyx Research Chemicals Ltd.
 Onyx Research Chemicals Ltd. Pharmaceuticals: MajorHealth Technology Part of Ipca Laboratories Ltd., Onyx Research Chemicals Ltd. is a British company that operates as a parent company. The company is based in Sunderland, UK. | Pharmaceuticals: Major | Director/Board Member | |
Elli Investments Ltd.
 Elli Investments Ltd. Hospital/Nursing ManagementHealth Services Elli Investments Ltd. operates as a holding company, which engages in the provision of elderly care and specialized care services. It operates through the Four Seasons Health Care and Brighterkind segments. The company was founded on May 31, 2012 and is headquartered in Cheltenham, the United Kingdom. | Hospital/Nursing Management | Director/Board Member | |
| LochGlen Whisky Co. Ltd. | Director/Board Member | ||
Optibiotix Ltd.
 Optibiotix Ltd. BiotechnologyHealth Technology Part of Optibiotix Health Plc, Optibiotix Ltd. is a British company that develops biological products for digestive health. The company is based in Heslington, UK. The company was founded in 2012 by Stephen Patrick O'Hara, who has been the CEO since 2012. Optibiotix was acquired by Optibiotix Health Plc on August 05, 2014 for $122.72 million. | Biotechnology | Director/Board Member | |
Source Bioscience Healthcare
 Source Bioscience Healthcare Medical SpecialtiesHealth Technology Source Bioscience Healthcare manufactures and supplies analytical testing laboratory products and provides laboratory services. The private company is based in Nottingham, UK. | Medical Specialties | Director/Board Member | |
| EKF Diagnostics Ltd. | Director/Board Member | ||
| EKF Molecular Diagnostics Ltd. | Director/Board Member | ||
Collagen Solutions (UK) Ltd.
 Collagen Solutions (UK) Ltd. BiotechnologyHealth Technology Collagen Solutions (UK) Ltd. manufactures medical grade biomedical collagen components for use in regenerative medicines, medical devices, and in-vitro diagnostics. It offers reagents and protocols; and specific collagen formulations for applications, such as sponges, films, and powders. The company is headquartered in London, the United Kingdom. | Biotechnology | Director/Board Member | |
| COLLAGEN SOLUTIONS PLC | Biotechnology | Director/Board Member Chairman | |
| J & K (Cardiff) Ltd. | Director/Board Member | ||
| YOURGENE HEALTH | Medical Specialties | Chairman Director of Finance/CFO | |
Diagnostic Capital
 Diagnostic Capital Investment ManagersFinance Diagnostic Capital provides investment advice. | Investment Managers | Director/Board Member | |
| OPTIBIOTIX HEALTH PLC | Biotechnology | Chairman Corporate Secretary | |
| Spectrum (General Partner) Ltd. | Director/Board Member | ||
Jellagen Pty Ltd.
 Jellagen Pty Ltd. Food: Meat/Fish/DairyConsumer Non-Durables Jellagen Pty Ltd. produces research grade functional non-mammalian collagen products. The company was founded by Andrew Mearns Spragg and Alex Muhlholzl in May 2013 and is headquartered in Pembroke Dock, the United Kingdom. | Food: Meat/Fish/Dairy | Director/Board Member | |
| Rosnes Ltd. | Director/Board Member | ||
| Scipac Ltd. | Director/Board Member | ||
Lexington Corporate Advisors Ltd.
 Lexington Corporate Advisors Ltd. Investment ManagersFinance Lexington Corporate Advisors Ltd. provides investment solutions. The company was incorporated on August 11, 2015 and is headquartered in Cardiff, the United Kingdom. | Investment Managers | Director/Board Member | |
B+B Smartworx Ltd.
 B+B Smartworx Ltd. Telecommunications EquipmentElectronic Technology B+B Smartworx Ltd. designs and builds device connectivity and network infrastructure products. The company's solutions include industrial automation, energy and natural resources, transportation transaction management and security. It's products include ethernet serial device servers, ethernet infrastructure and wireless and cellular. The company was founded in 1983 and is headquartered in Galway, Ireland. | Telecommunications Equipment | Director/Board Member | |
| BBI Holdings Plc | Chairman Chief Executive Officer | ||
| Fine Art of Golf Ltd. | Director/Board Member | ||
| RENALYTIX PLC | Packaged Software | Chairman Chairman | |
Novel Technologies Holdings Ltd.
 Novel Technologies Holdings Ltd. Financial ConglomeratesFinance Novel Technologies Holdings Ltd. operates as an investment holding company. The company was founded on May 24, 2017 and is headquartered in Manchester, the United Kingdom. | Financial Conglomerates | Director/Board Member | |
| VERICI DX PLC | Medical/Nursing Services | Chairman | |
| GENINCODE PLC | Packaged Software | Director/Board Member | |
| TRELLUS HEALTH PLC | Internet Software/Services | Director/Board Member Chairman | |
| Calibre Communications Ltd. | Director/Board Member | ||
| CY Realisations Ltd. | Director/Board Member |
Statistics
International
| United Kingdom | 49 |
| Ireland | 2 |
Sectoral
| Health Technology | 15 |
| Finance | 9 |
| Technology Services | 5 |
| Consumer Services | 4 |
| Commercial Services | 3 |
Operational
| Director/Board Member | 332 |
| Chairman | 65 |
| Independent Dir/Board Member | 39 |
| Corporate Officer/Principal | 28 |
| Founder | 20 |
Most connected contacts
| Insiders | |
|---|---|
| Christopher Mills | 154 |
| David Evans | 70 |
| Simon Holden | 40 |
| Anthony Rudd | 32 |
| Cormac G. Kilty | 22 |
| Colin Willis | 20 |
| Malcolm Gillies | 17 |
| Julian Baines | 17 |
| Myles Halley | 16 |
| Sylvia Coleman | 14 |
| Giles Willits | 12 |
| Lisa Clement | 9 |
| Mark Collingbourne | 9 |
| Francis Keeling | 8 |
| Rory James-Duff | 5 |
- Stock Market
- Insiders
- Robert Naylor
- Company connections
